| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 4.66B | $ 4.03B | $ 3.62B | $ 2.91B | $ 2.45B |
| Gross Profit | $ 2.80B | $ 2.44B | $ 2.29B | $ 1.88B | $ 1.68B |
| Operating Income | $ 911.80M | $ 600.00M | $ 597.70M | $ 391.20M | $ 265.80M |
| EBITDA | $ 1.36B | $ 945.70M | $ 916.70M | $ 565.30M | $ 377.50M |
| Net Income | $ 836.30M | $ 576.20M | $ 541.50M | $ 341.20M | $ 216.90M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.00B | $ 2.58B | $ 2.72B | $ 2.46B | $ 2.73B |
| Total Assets | $ 6.34B | $ 6.48B | $ 6.26B | $ 5.39B | $ 4.93B |
| Total Debt | $ 1.39B | $ 2.59B | $ 2.59B | $ 2.15B | $ 2.16B |
| Net Debt | $ 472.00M | $ 1.98B | $ 2.03B | $ 1.50B | $ 1.11B |
| Total Liabilities | $ 3.59B | $ 4.38B | $ 4.20B | $ 3.26B | $ 2.89B |
| Stockholders' Equity | $ 2.75B | $ 2.10B | $ 2.07B | $ 2.13B | $ 2.04B |
| Cash Flow | |||||
| Free Cash Flow | $ 1.08B | $ 630.70M | $ 511.90M | $ 304.70M | $ 53.30M |
| Operating Cash Flow | $ 1.44B | $ 989.50M | $ 748.50M | $ 669.50M | $ 442.50M |
| Investing Cash Flow | $ 536.00M | $ -207.50M | $ -507.20M | $ -521.50M | $ -216.10M |
| Financing Cash Flow | $ -1.69B | $ -734.80M | $ -318.60M | $ -552.50M | $ 10.40M |
Dexcom (CH:DC4)
:DC4
